  Progressive myoclonus epilepsies ( PMEs) constitute a cluster of inherent , genetically diverse , rare seizure<symptom> disorders characterized by ataxia<symptom> , tonic-clonic seizures<symptom> , and action myoclonus. Recently , a mutation in the KCNC1 gene ( Arg320His) was described in a group of PME patients. The KCNC1 gene encodes the K